Observational studyInternational immunopharmacology2022
Tocilizumab in critically ill COVID-19 patients: An observational study.
Muhammad Z Mushtaq et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it